Research Areas
- Prototyping and fabrication of an integrated plate system with pillars and perfusion wells
- Synthesis of tunable hydrogels (“bioink”) for miniature 3D bioprinting
- Development of microscale 3D human cell printing technology on pillar/perfusion plate
platforms for tissue engineering and disease modeling
- Liver, intestine, and pancreas organoid culture for modeling type II diabetes
- Brain organoid culture for developmental toxicology
- Gene-edited liver organoid culture for disease modeling and predictive drug screening
- Gene-edited intestine organoid culture for predictive pharmacokinetics studies
- Liver tumor organoid culture from biopsy samples for personalized cancer therapy
- Multi-organoid co-culture on pillar/perfusion plates for disease modeling
- Establishment of high-content imaging (HCI) assays on 3D-cultured human cells
- Development of viral gene delivery systems to study individual-dependent, adverse drug responses
- Development of predictive assays to assess the efficacy of antimicrobial agents
Microarray Chip Platforms
3D Cell/Tissue Culture on 384PillarPlate
Commercial Applications of Miniaturized Human Tissue Constructs
- Predictive assessment of drug toxicity, efficacy, and pharmacokinetics for preclinical evaluations on bioprinted tissue constructs
- Human disease modeling on bioprinted tissue constructs
- Systematic study of cellular microenvironments for tissue engineering and regenerative medicines
- High-throughput, high-content screening of drug candidates and environmental toxicants